MDA-19
跳至導覽
跳至搜尋
| File:MDA-19.svg | |
| 法律規範狀態 | |
|---|---|
| 法律規範 |
|
| 識別資訊 | |
| |
| CAS號 | 1048973-47-2( 1104302-26-2 (alternative)) check |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| E編碼 | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Module:EditAtWikidata第29行Lua錯誤:attempt to index field 'wikibase' (a nil value) |
| 化學資訊 | |
| 化學式 | C21H23N3O2 |
| 摩爾質量 | 349.43 g·mol−1 |
| 3D模型(JSmol) | |
| |
MDA-19(也稱為BZO-HEXOXIZID)是一種含氮有機化合物,化學式C
21H
23N
3O
2,可作為大麻素受體CB2的強效選擇性激動劑[2][3]。
參考文獻[編輯]
- ↑ Anvisa. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-07-24 (2023-07-25) [2023-08-27]. (原始內容存檔於2023-08-27) (português do Brasil).
- ↑ Systematic Naming for MDA 19. www.caymanchem.com. [2025-03-22] (English).
- ↑ New Systematic Naming for Synthetic Cannabinoid "MDA-19" and its Related Analogues: BZO-HEXOXIZID, 5F-BZO-POXIZID, and BZO-POXIZID. 31 August 2021.